High costs, poor training deepen India’s stinging snakebite toll, Pg10

Key Highlights:

• The World Health Organization recognizes snakebite envenomation as a neglected tropical disease, causing 0.8-1.3 lakh deaths worldwide annually.
• India accounts for nearly half of the world’s snakebite deaths, with recent estimates suggesting 45,000-58,000 deaths per year.
• The "big four" snakes in India responsible for most deaths are the Indian cobra, common krait, Russell’s viper, and saw-scaled viper.
• Treatment costs can range from ₹3,900 at public facilities to around ₹27,400 at private facilities, creating a significant financial burden.

Detailed Insights:

• Snakebite victims often die outside hospitals due to lack of prompt antivenom treatment, leading to death or permanent disabilities.
• The clinical outcome depends on venom quantity, snake size, and venom toxicity; without antivenom, survival is unlikely if a significant amount of venom is injected.
• Despite eligibility for the Ayushman Jan Aarogya health card, only 12% of victims had insurance cover, highlighting gaps in healthcare access.
• Inadequate training of healthcare providers and reliance on faith healers contribute to delays in seeking appropriate medical care.
• Next-generation therapies are needed to address severe symptoms associated with snakebites and improve treatment outcomes.

Key Concepts Involved:

• Snakebite Envenomation: The poisoning caused by the injection of snake venom through a bite.
• Antivenom: A biological product used to treat snakebite envenomation, made by neutralizing venom with antibodies.
• Neglected Tropical Disease: A diverse group of communicable diseases that affect impoverished populations in tropical and subtropical regions.